AstraZeneca says reports its COVID-19 vaccine has low efficacy in elderly people are 'completely incorrect'
4 years, 1 month ago

AstraZeneca says reports its COVID-19 vaccine has low efficacy in elderly people are 'completely incorrect'

ABC  

Pharmaceutical company AstraZeneca has denied media reports that its COVID-19 vaccine is not very effective for people over 65. Key points: AstraZeneca said media reports about the vaccine's efficacy in the elderly were "completely incorrect" The company said strong immune responses had been shown in blood analysis of elderly trial participants The Oxford/AstraZeneca vaccine has not yet been approved in Australia In separate reports, German daily papers Handelsblatt and Bild said the vaccine had an efficacy of 8 per cent or less than 10 per cent, respectively, in people over 65 years of age. In a statement, AstraZeneca described the German media reports saying its COVID-19 vaccine was shown to have a very low efficacy in the elderly as "completely incorrect". It also said strong immune responses to the vaccine had been shown in blood analysis of elderly trial participants.

Elderly Covid German Vaccine Reports Astrazeneca Media Reports Efficacy Efficacy Data Elderly Trial Participants  approved  covid19  low  elderly  incorrect  reports  data  vaccine  trial  astrazeneca  uk  efficacy  completely

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
10 months, 1 week ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
10 months, 1 week ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca: What are the rare side effects of the Covid jab?
10 months, 1 week ago

AstraZeneca: What are the rare side effects of the Covid jab?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy AstraZeneca has announced it initiated a worldwide withdrawal of its Covid-19 …

The truth about AstraZeneca’s Covid vaccine
10 months, 2 weeks ago

The truth about AstraZeneca’s Covid vaccine

The Independent  

Within 24 hours of my first Covid vaccine, I was in bed, feeling like I had just gone 10 rounds with Mike Tyson. Nonetheless, when it came to the second shot of the Oxford-AstraZeneca Covid vaccine, I was at the front of the queue in the full knowledge of what might happen. Airfinity, a disease forecasting tech company, used that …

AstraZeneca pulls its COVID-19 vaccine from the European market
10 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca begins global withdrawal of Covid-19 vaccines: This is the reason
10 months, 2 weeks ago

AstraZeneca begins global withdrawal of Covid-19 vaccines: This is the reason

Op India  

On Tuesday, AstraZeneca announced that it has begun the global withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the epidemic. “As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” AstraZeneca said. AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorisations for Vaxzevria …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
10 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
10 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
10 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle
1 year, 2 months ago

AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle

Daily Mail  

AstraZeneca is is facing tens of millions of pounds in compensation claims from 35 alleged victims over complications they say were caused by the Covid-19 vaccine. The pharmaceutical giant, which developed its jab in partnership with the University of Oxford, is set to face a High Court battle over claims the vaccine is 'defective' MP Sir Jeremy Wright has been …

The victims of AstraZeneca's vaccine
1 year, 10 months ago

The victims of AstraZeneca's vaccine

Daily Mail  

Jab complications were rare but the massive rollout saw dozens of Brits killed Covid vaccines are estimated to have saved millions of lives, by both protecting people from the virus and helping end the paralysing series of lockdowns. An inquest heard he was told there was no Pfizer jab in stock and was given out-of-date information in relation to blood …

Study: Pfizer COVID pill showed no benefit in younger adults
2 years, 6 months ago

Study: Pfizer COVID pill showed no benefit in younger adults

Associated Press  

WASHINGTON — Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday. The results from a 109,000-patient Israeli study are likely to renew questions about the U.S. government’s use of Paxlovid, which has become the go-to treatment for …

Study: Pfizer COVID pill showed no benefit in younger adults
2 years, 6 months ago

Study: Pfizer COVID pill showed no benefit in younger adults

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pfizer's COVID-19 pill appears to …

Pfizer COVID pill showed no benefit in adults under 65, study finds
2 years, 6 months ago

Pfizer COVID pill showed no benefit in adults under 65, study finds

LA Times  

Paxlovid may provide little benefit for adults younger than 65 with COVID-19 while still reducing the risk of hospitalization and death for higher-risk seniors, according to a new study from Israel. Pfizer’s COVID-19 pill appears to provide little or no benefit for adults under 65 while still reducing the risk of hospitalization and death for high-risk seniors, according to a …

New plant-based Covid vaccine 70% effective against variants: Study
2 years, 10 months ago

New plant-based Covid vaccine 70% effective against variants: Study

India Today  

A new plant-based Covid-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. The study, published on Thursday in the New England Journal of Medicine, shows that the vaccine efficacy was 69.5 per cent against any symptomatic Covid-19 caused by five …

'New plant-based COVID-19 vaccine 70% effective against variants'
2 years, 10 months ago

'New plant-based COVID-19 vaccine 70% effective against variants'

Firstpost  

The vaccine developed by researchers at Canadian biotechnology company Medicago contains coronavirus-like particles produced in plants which are combined with an adjuvant that helps vaccines work better Toronto: A new plant-based COVID-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 10 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 11 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

AstraZeneca set to abandon push for US vaccine approval
3 years ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Covid-19 Australia: UK doctor slams scientists and politicians of damaging reputation of AstraZeneca
3 years, 1 month ago

Covid-19 Australia: UK doctor slams scientists and politicians of damaging reputation of AstraZeneca

Daily Mail  

An Oxford scientist who worked on the AstraZeneca vaccine believes scientists and politicians 'probably killed hundreds of thousands of people' by damaging the reputation of the jab. Professor Sir John Bell claims critical comments from leaders such as French President Emmanuel Macron had eroded public trust in the vaccine globally. An Oxford scientist who worked on the AstraZeneca vaccine claims …

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?
3 years, 2 months ago

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?

ABC  

Linda Fisher and her husband Ken are members of Generation AZ: the group of those aged 60+ who lined up for an AstraZeneca vaccine, the only one available to their age group for some time. "If Omicron didn't exist you would probably feel pretty relaxed around Christmas this year," he says. "Most people have a certain degree of immunity which …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years, 2 months ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm
3 years, 3 months ago

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm

The Telegraph  

It is the key question puzzling scientists and commentators – how is Britain managing to weather the latest deadly Covid storm while our European neighbours' defences are crumbling? He suggested that the durability of T-cells from the Oxford/AstraZeneca jab could be keeping older people safer than those on the continent, preventing hospitilisations and deaths even though virus cases are still …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 4 months ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

AstraZeneca seems to be losing efficacy fastest: blood bank
3 years, 4 months ago

AstraZeneca seems to be losing efficacy fastest: blood bank

NL Times  

Vaccinated people between the ages of 61 and 65 have a lot fewer antibodies against the coronavirus than vaccinated people in other age groups. According to Zaaijer, the very youngest donors, aged 18 to 25, have on average almost eight times more antibodies in their blood than people in the group aged 61 to 65. An older age group, aged …

Not all vaccine experts are convinced COVID-19 vaccine boosters are needed
3 years, 4 months ago

Not all vaccine experts are convinced COVID-19 vaccine boosters are needed

Daily Mail  

Even as booster shots of COVID-19 vaccines become widely available in the U.S., some vaccine experts are not convinced that the shots are broadly necessary. While studies indicate that older adults have a higher risk of severe breakthrough Covid cases, limited data are available on the need for boosters among younger age groups. 'I don't think that we have evidence …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 5 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 5 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

How effective are the Pfizer, Moderna and AstraZeneca COVID-19 vaccines?
3 years, 5 months ago

How effective are the Pfizer, Moderna and AstraZeneca COVID-19 vaccines?

ABC  

When COVID-19 vaccines were being developed, manufacturers had to hit an efficacy rate of 50 per cent before their jabs could get approval. Australian National Centre for Immunisation Research and Surveillance director Kristine Macartney said it was important that people do not just look at one study or compare one study with another because, often, "the studies are done in …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 6 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

CDC finds the unvaccinated are 11 times more likely to die of COVID
3 years, 6 months ago

CDC finds the unvaccinated are 11 times more likely to die of COVID

LA Times  

New U.S. studies released Friday show the COVID-19 vaccines remained highly effective against hospitalizations and death even as the extra-contagious Delta variant swept the country. As Delta surged in early summer, those who were unvaccinated were 4.5 times more likely than the fully vaccinated to get infected, more than 10 times more likely to be hospitalized and 11 times more …

Worried about getting AstraZeneca? The experts answer your questions
3 years, 6 months ago

Worried about getting AstraZeneca? The experts answer your questions

ABC  

A lot of Australians are still worried about the AstraZeneca vaccine but experts say there is no reason for the vast majority not to get it. Dr Price says those conditions include: Central venous sinus thrombosis Heparin-induced thrombocytopenia with thrombosis, where heparin is the medication Capillary leak syndrome Antiphospholipid syndrome Idiopathic splanchnic vein thrombosis Polysorbate 80 anaphylaxis Previous thrombocytopenia syndrome …

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting
3 years, 6 months ago

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting

ABC  

The nation's peak medical body has issued a stark warning: if you're over 60 and are hoping to get the Pfizer COVID-19 jab, you could die waiting. Key points: More than half a million Australians aged between 60 and 69 haven't received a single COVID-19 vaccine dose The Prime Minister has penned a letter urging Australians over 60 to get …

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows
3 years, 6 months ago

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows

LA Times  

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer plant in Portage, Mich. COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with the AstraZeneca or Pfizer shots, according to a large U.K. study. For every 10 million people who receive the first dose of AstraZeneca, about 66 more will …

Pfizer COVID-19 jab declines faster than AstraZeneca: study
3 years, 7 months ago

Pfizer COVID-19 jab declines faster than AstraZeneca: study

The Hindu  

The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. It found that "the dynamics of immunity following …

Pfizer, AstraZeneca Covid vaccines less effective against Delta variant: Oxford-led study
3 years, 7 months ago

Pfizer, AstraZeneca Covid vaccines less effective against Delta variant: Oxford-led study

India TV News  

Pfizer, AstraZeneca Covid vaccines less effective against Delta variant: Oxford-led study The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new infections. The COVID-19 vaccines by Pfizer and AstraZeneca are less effective against the Delta variant of coronavirus compared to the Alpha variant, according to a study …

COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 7 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. …

AstraZeneca COVID vaccine safe for breastfeeding women, health experts say, after official advice causes confusion
3 years, 7 months ago

AstraZeneca COVID vaccine safe for breastfeeding women, health experts say, after official advice causes confusion

ABC  

When official health advice recently changed for people under 40 living in COVID-19 outbreak areas like Sydney to strongly consider getting the AstraZeneca vaccine, Sophie Hill quickly made an appointment to see her GP. "If there are breastfeeding women who want the AstraZeneca vaccine and they are getting advice that they should wait, but they perceive that the risk is …

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available
3 years, 7 months ago

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available

ABC  

Young Australians in locked-down cities are rolling up their sleeves in massive numbers to protect themselves with the AstraZeneca vaccine. Unvaccinated younger workers who cannot work from home are continuing to circulate the virus in Sydney, and the NSW government is hoping higher vaccination rates will put downward pressure on the infection curve, as well as reduce the number of …

Young people explain why they are seeking out COVID-19 jabs
3 years, 7 months ago

Young people explain why they are seeking out COVID-19 jabs

ABC  

Many months after Australians first started getting coronavirus vaccines, incremental changes are enabling more young people to access the jabs. Young people getting their first dose at the vaccine hub at Carlton's Royal Exhibition Building shared some of their motivations, thoughts and hopes as they took the crucial step. "Since they allowed AstraZeneca into the state facilities I think more …

Getting a COVID-19 vaccination — who's eligible, how to book and where to go
3 years, 7 months ago

Getting a COVID-19 vaccination — who's eligible, how to book and where to go

ABC  

Each day, thousands of Queenslanders are rolling up their sleeves and getting themselves vaccinated against COVID-19. Certain groups are also eligible if you are: An Aboriginal and Torres Strait Islander person aged 16 and over An NDIS participant or unpaid or informal carer of NDIS participants of any age Pregnant A quarantine or border worker A health care worker, aged …

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta
3 years, 7 months ago

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta

ABC  

Back in April, the Prime Minister stood up at a late-night press conference and announced the Pfizer vaccine would be preferred over AstraZeneca for most people under 50. Key points: Two doses of AstraZeneca is 92 per cent effective against hospitalisation from the Delta variant, a UK study found Two doses of AstraZeneca is 92 per cent effective against hospitalisation …

New Zealand provisionally approves AstraZeneca vaccine for people aged above 18
3 years, 7 months ago

New Zealand provisionally approves AstraZeneca vaccine for people aged above 18

India TV News  

New Zealand provisionally approves AstraZeneca vaccine for people aged above 18 New Zealand secured 7.6 mn doses of AstraZeneca vaccine, enough for 3.8 mn people, through an advance purchase agreement with the company last year, Acting Minister for Covid Response Ayesha Verrall said in a statement. New Zealand's regulatory authority Medsafe on Thursday granted provisional approval of the AstraZeneca Covid-19 …

COVID-19: Are mix-and-match vaccines the way forward?
3 years, 7 months ago

COVID-19: Are mix-and-match vaccines the way forward?

The Hindu  

A new British study confirms reports that a combination of the AstraZeneca and BioNTech vaccines triggers a stronger immune response than two doses of AstraZeneca. Researchers at the University of Oxford have found that patients who received a dose of AstraZeneca followed by a dose of the BioNTech-Pfizer vaccine four weeks later developed a higher number of antibodies than those …

Australia's sluggish vaccination figures aren't all because of poor supply. Here's what's going wrong
3 years, 7 months ago

Australia's sluggish vaccination figures aren't all because of poor supply. Here's what's going wrong

ABC  

More than 150 days into Australia's vaccination rollout, no age group is yet to reach a first dose vaccination rate of 80 per cent. The current uptake is likely to be far behind the vaccination target for Australia that is due to be set by National Cabinet — using modelling from the Doherty Institute — in coming weeks as part …

ATAGI urges all adult Sydneysiders to 'strongly consider' the AstraZeneca vaccine amid NSW COVID outbreak
3 years, 7 months ago

ATAGI urges all adult Sydneysiders to 'strongly consider' the AstraZeneca vaccine amid NSW COVID outbreak

ABC  

All adults in Greater Sydney should “strongly consider” getting vaccinated with any available vaccine, including AstraZeneca, Australia's expert vaccines body says. Key points: ATAGI says it updated the advice to reflect the worsening COVID situation in Sydney Deputy Chief Medical Officer Michael Kidd says there is evidence the Delta strain has a more serious impact on younger people The vaccine …

Hundreds of unused AstraZeneca doses in NT could be used in Timor-Leste, WHO doctor says
3 years, 8 months ago

Hundreds of unused AstraZeneca doses in NT could be used in Timor-Leste, WHO doctor says

ABC  

Hundreds of unused AstraZeneca doses provided to the Northern Territory's Aboriginal health services are due to expire soon after Pfizer became the preferred vaccine for the remote rollout. Key points: Hundreds of AstraZeneca vaccines in the NT need to be redistributed A WHO expert says Australia's AstraZeneca supplies are critical to the rollout in Timor-Leste Australia has committed to giving …

TGA links deaths of 44yo Tasmanian man and 48yo Victorian woman to AstraZeneca vaccine
3 years, 8 months ago

TGA links deaths of 44yo Tasmanian man and 48yo Victorian woman to AstraZeneca vaccine

ABC  

The Therapeutic Goods Administration has been notified of two more fatal cases of the rare blood clotting disorder related to AstraZeneca. Key points: These are the fifth and sixth deaths linked to the first dose of the AstraZeneca vaccine from 6.1 million doses, according to the TGA These are the fifth and sixth deaths linked to the first dose of …

Prime Minister says 'sorry' for problems with COVID-19 vaccine rollout program
3 years, 8 months ago

Prime Minister says 'sorry' for problems with COVID-19 vaccine rollout program

ABC  

Prime Minister Scott Morrison says he is "sorry" for the challenges his government had with rolling out the COVID-19 vaccine earlier in the year. Key points: The Prime Minister has apologised for early issues with the COVID-19 vaccine rollout The Prime Minister has apologised for early issues with the COVID-19 vaccine rollout Vaccinations hit a new daily record, with 1 …

ATAGI advice on AstraZeneca COVID-19 vaccine remains unchanged for under 60s
3 years, 8 months ago

ATAGI advice on AstraZeneca COVID-19 vaccine remains unchanged for under 60s

ABC  

The expert panel advising on Australia's COVID-19 vaccine rollout has not changed its advice limiting AstraZeneca vaccines to people over 60. Key points: ATAGI, the government's expert panel on vaccines, meets each week to discuss the government's response to the pandemic; The panel did not change its advice limiting AstraZeneca to people over 60 Prime Minister Scott Morrison indicated the …

Discover Related